ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2017

Abstract Number: 1695

Baseline Characteristics and Outcomes in a Retrospective Cohort of Patients with Systemic Sclerosis Related Interstitial Lung Disease

Robert L. Mango1, Eric L. Matteson2, Cynthia S. Crowson3, Jay H. Ryu4 and Ashima Makol2, 1Internal Medicine, Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, MN, 2Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, 3Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, 4Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2017

Date of first publication: September 18, 2017

Keywords: interstitial lung disease, scleroderma and systemic sclerosis

Session Information

Date: Monday, November 6, 2017

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Interstitial lung disease (ILD) is a major contributor to morbidity and mortality in systemic sclerosis (SSc). We sought to identify the distribution of clinical characteristics, comorbidities, pulmonary disease patterns, and outcomes in a retrospective cohort of SSc-ILD.

Methods: A retrospective review of medical records was conducted to identify patients with SSc seen at a single tertiary referral center in 2000-2013 within 1 year of ILD diagnosis. All patients met the 2013 ACR/EULAR classification criteria for SSc. Patients were included only if at least 1 year of follow up data was available. Baseline demographics, comorbidities and clinical characteristics were collected, in addition to pulmonary function tests, lung imaging, and echocardiogram for 3 years after ILD diagnosis. Cox models were used to examine associations between potential risk factors and progression or mortality.

Results: A total of 126 patients with SSc-ILD were identified (87 [69%] female; mean age: 57.5, range 31-82 years). Based on high resolution chest CT (or biopsy when available), 108 (86%) were characterized as nonspecific interstitial pneumonia (NSIP), 17 (13%) as usual interstitial pneumonia (UIP), 1 as unclassifiable ILD. Pulmonary hypertension (PHTN) was noted in 44 (35%) at baseline, and this did not differ between ILD subtypes. Patients with UIP were more likely than those with NSIP to have chronic obstructive pulmonary disease (COPD) at baseline (24% vs 5%, p = 0.005). 89% had limited cutaneous SSc, 7% had diffuse cutaneous, and 4% SSc sine scleroderma. SSc specific serologies (i.e., SCL-70, centromere, and/or RNA Pol III) were positive in 56 (46%) patients, somewhat more common in NSIP than UIP (49% vs 25%; p=0.07). Baseline initial forced vital capacity (FVC) and diffusion capacity (DLco) were not significantly different between ILD subtypes. Progression to DLco < 40% predicted or too ill to perform DLco was noted in 39% (95% CI 30% – 48%) by 3 years and did not significantly differ between ILD patterns (p=0.64). Risk factors for progression included baseline DLco (p < 0.001), FVC (p = 0.001) and PHTN (p = 0.002). Only 5 patients progressed to FVC < 50% predicted. During a median of 5.0 years of follow-up, five-year survival was 86% (95% CI 80 – 92%), and was only marginally worse in UIP than NSIP (hazard ratio [HR]: 2.0; p=0.057). Risk factors for mortality included comorbid COPD, hypertension and those identified for progression. The presence of inflammatory arthritis at baseline (16 patients, 13%) appeared to be a good prognostic indicator for mortality (HR 0.21, 95% CI 0.05 – 0.89).

Conclusion: Outcomes were overall somewhat better in SSc-ILD compared with those described in idiopathic pulmonary fibrosis, consistent with previous studies of connective tissue disease related ILD. ILD subtype had marginal prognostic significance in this cohort of patients with SSc-ILD. Baseline FVC and DLco, comorbid COPD, hypertension, and pulmonary hypertension at any time were risk factors for a poor prognosis. These findings highlight the importance of a thorough baseline pulmonary evaluation in predicting outcomes in patients with SSc-ILD.


Disclosure: R. L. Mango, None; E. L. Matteson, None; C. S. Crowson, None; J. H. Ryu, None; A. Makol, None.

To cite this abstract in AMA style:

Mango RL, Matteson EL, Crowson CS, Ryu JH, Makol A. Baseline Characteristics and Outcomes in a Retrospective Cohort of Patients with Systemic Sclerosis Related Interstitial Lung Disease [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/baseline-characteristics-and-outcomes-in-a-retrospective-cohort-of-patients-with-systemic-sclerosis-related-interstitial-lung-disease/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/baseline-characteristics-and-outcomes-in-a-retrospective-cohort-of-patients-with-systemic-sclerosis-related-interstitial-lung-disease/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology